首页> 美国卫生研究院文献>Disease Markers >Low Plasma Levels of FGF-2 and PDGF-BB Are Associated with Cardiovascular Events in Type II Diabetes Mellitus (Diabetes Heart Study)
【2h】

Low Plasma Levels of FGF-2 and PDGF-BB Are Associated with Cardiovascular Events in Type II Diabetes Mellitus (Diabetes Heart Study)

机译:FGF-2和PDGF-BB的低血浆水平与II型糖尿病的心血管事件相关(糖尿病心脏研究)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objective: We tested associations of the growth factors VEGF, FGF-2, HGF and PDGF-BB with coronary artery calcium scores and cardiovascular events (CVD) in type 2 diabetes mellitus (T2DM). Methods: A cross-sectional study selected 40 frequency matched (by age, gender and race) subjects with T2DM from the first (0–111) and the third (> 1400) coronary artery calcium (CAC) score tertiles in the Diabetes Heart Study (DHS), in which 36 were with and 41 were without history of CVD events. Plasma levels of VEGF, FGF-2, HGF and PDGF-BB were measured in all subjects. Results: None of the growth factors was significantly different between the first and third CAC score tertiles. Mean plasma FGF-2 and PDGF-BB levels were significantly higher in the group without prior CVD events compared with the group with prior CVD events [mean(95%CI): 219.20 (194.42–247.15) vs. 152.93 (135.64–172.43) pg/ml, p = 0.03] and [mean(95%CI): 106.70 (89.12–127.74) vs. 61.56 (50.91–74.44) pg/ml, p = 0.03], respectively. Subgroup analysis in the first CAC tertile showed a significantly higher PDGF-BB levels in those without compared with those with CVD events [mean (95%CI): 208.36 (190.57–228.15) vs. 102.93 (80.64–125.21) pg/ml, p = 0.004]. Conclusion: Plasma growth factor levels were not significantly different between the extremes of CAC scores in T2DM. However, low plasma levels of PDGF-BB and FGF-2 are associated with prior cardiovascular events in T2DM. Studies are needed to confirm our results and also to establish temporality of this association.
机译:目的:我们测试了2型糖尿病(T2DM)中生长因子VEGF,FGF-2,HGF和PDGF-BB与冠状动脉钙积分和心血管事件(CVD)的关联。方法:一项横断面研究从糖尿病心脏研究的第一(0-111)和第三(> 1400)冠状动脉钙(CAC)评分三分位数中选出40位频率匹配(按年龄,性别和种族划分)的T2DM受试者(DHS),其中36例有CVD事件,41例无CVD事件史。在所有受试者中测量血浆VEGF,FGF-2,HGF和PDGF-BB的水平。结果:第一和第三CAC得分三分位数之间的生长因子均无显着差异。没有发生过CVD事件的组的平均血浆FGF-2和PDGF-BB水平明显高于发生过CVD事件的组[平均值(95%CI):219.20(194.42–247.15)vs. 152.93(135.64–172.43) pg / ml,p = 0.03]和[平均值(95%CI):106.70(89.12–127.74)vs. 61.56(50.91–74.44)pg / ml,p = 0.03]。第一个CAC三分位数的亚组分析显示,未发生CVD的患者的PDGF-BB水平显着高于发生CVD事件的患者[平均值(95%CI):208.36(190.57–228.15)vs. 102.93(80.64–125.21)pg / ml, p = 0.004]。结论:血浆生长因子水平在T2DM中CAC评分的极值之间没有显着差异。但是,PDGF-BB和FGF-2的低血浆水平与T2DM中先前的心血管事件有关。需要进行研究以确认我们的结果并确定这种关联的时间性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号